Tissue Inflammation and Insulin Resistance Receptor Contributes to Obese Adipose The Complement Anaphylatoxin C5a

Obese adipose tissue (AT) inflammation contributes critically to development of insulin resistance. The complement anaphylatoxin C5a receptor (C5aR) has been implicated in inflammatory processes and as regulator of macrophage activation and polarization. However, the role of C5aR in obesity and AT inflammation has not been addressed. We engaged the model of diet-induced obesity and found that expression of C5aR was significantly upregulated in the obese AT, compared with lean AT. In addition, C5a was present in obese AT in the proximity of macrophage-rich crownlike structures. C5aR-sufficient and -deficient mice were fed a high-fat diet (HFD) or a normal diet (ND). C5aR deficiency was associated with increased ATweight upon ND feeding in males, but not in females, and with increased adipocyte size upon ND and HFD conditions in males. However, obese C5aR 2 / 2 mice displayed improved systemic and AT insulin sensitivity. Improved AT insulin sensitivity in C5aR 2 / 2 mice was associated with reduced accumulation of total and proinflammatory M1 macrophages in the obese AT, increased expression of IL-10, and decreased AT fibrosis. In contrast, no difference in b cell mass was observed owing to C5aR deficiency under an HFD. These results suggest that C5aR contributes to macrophage accumulation and M1 polarization in the obese AT and thereby to AT dysfunction and development of AT insulin resistance. The Journal of Immunology , 2013, 191: 000–000.

[1]  Yongjie Ma,et al.  Hydrodynamic delivery of mIL10 gene protects mice from high-fat diet-induced obesity and glucose intolerance. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  K. Cianflone,et al.  C5a Receptor Deficiency Alters Energy Utilization and Fat Storage , 2013, PloS one.

[3]  F. Kronenberg,et al.  Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus , 2013, Nature Medicine.

[4]  M. Stoffel,et al.  Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b , 2013, Nature.

[5]  John D Lambris,et al.  The role of the complement system in metabolic organs and metabolic diseases. , 2013, Seminars in immunology.

[6]  D. Fairlie,et al.  C5aR and C3aR antagonists each inhibit diet‐induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  T. Chavakis,et al.  The role of innate immune cells in obese adipose tissue inflammation and development of insulin resistance , 2013, Thrombosis and Haemostasis.

[8]  Y. Tseng,et al.  Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. , 2013, The Journal of clinical investigation.

[9]  S. Woods,et al.  Rapid and Weight-Independent Improvement of Glucose Tolerance Induced by a Peptide Designed to Elicit Apoptosis in Adipose Tissue Endothelium , 2012, Diabetes.

[10]  S. Bornstein,et al.  Lymphocytes in obesity-related adipose tissue inflammation , 2012, Diabetologia.

[11]  John D Lambris,et al.  Platelets Contribute to the Pathogenesis of Experimental Autoimmune Encephalomyelitis , 2012, Circulation research.

[12]  R. Jotwani,et al.  The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss , 2012, Nature Immunology.

[13]  J. M. Suh,et al.  A PPARγ-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis , 2012, Nature.

[14]  A. Klip,et al.  Conditioned medium from hypoxia-treated adipocytes renders muscle cells insulin resistant. , 2011, European journal of cell biology.

[15]  C. Weber,et al.  Atherosclerosis: current pathogenesis and therapeutic options , 2011, Nature Medicine.

[16]  D. Fairlie,et al.  Inhibition of Inflammation and Fibrosis by a Complement C5a Receptor Antagonist in DOCA-Salt Hypertensive Rats , 2011, Journal of cardiovascular pharmacology.

[17]  D. Cota,et al.  Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice , 2011, Diabetologia.

[18]  A. Chawla,et al.  Macrophage-mediated inflammation in metabolic disease , 2011, Nature Reviews Immunology.

[19]  C. Lumeng,et al.  Adipose tissue macrophages: phenotypic plasticity and diversity in lean and obese states , 2011, Current opinion in clinical nutrition and metabolic care.

[20]  John D Lambris,et al.  Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis. , 2010, Blood.

[21]  M. Delibegović,et al.  In vivo differential effects of fasting, re-feeding, insulin and insulin stimulation time course on insulin signaling pathway components in peripheral tissues. , 2010, Biochemical and biophysical research communications.

[22]  John D Lambris,et al.  Complement: a key system for immune surveillance and homeostasis , 2010, Nature Immunology.

[23]  G. Smyth,et al.  Pro-Inflammatory CD11c+CD206+ Adipose Tissue Macrophages Are Associated With Insulin Resistance in Human Obesity , 2010, Diabetes.

[24]  K. Strissel,et al.  Dynamic, M2-Like Remodeling Phenotypes of CD11c+ Adipose Tissue Macrophages During High-Fat Diet–Induced Obesity in Mice , 2010, Diabetes.

[25]  H. Ellingsgaard,et al.  Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes. , 2009, Physiology.

[26]  K. Cianflone,et al.  C5a- and ASP-mediated C5L2 activation, endocytosis and recycling are lost in S323I-C5L2 mutation. , 2009, Molecular immunology.

[27]  J. Lamb,et al.  The C3a Anaphylatoxin Receptor Is a Key Mediator of Insulin Resistance and Functions by Modulating Adipose Tissue Macrophage Infiltration and Activation , 2009, Diabetes.

[28]  J. Luckett,et al.  Dual role of complement in adipose tissue. , 2009, Molecular immunology.

[29]  P. Iyengar,et al.  Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of Collagen VI , 2008, Molecular and Cellular Biology.

[30]  A. Saltiel,et al.  Phenotypic Switching of Adipose Tissue Macrophages With Obesity Is Generated by Spatiotemporal Differences in Macrophage Subtypes , 2008, Diabetes.

[31]  S. Woods,et al.  The role of GM-CSF in adipose tissue inflammation. , 2008, American journal of physiology. Endocrinology and metabolism.

[32]  A. Chawla,et al.  Mechanisms of macrophage activation in obesity-induced insulin resistance , 2008, Nature Clinical Practice Endocrinology &Metabolism.

[33]  J. Olefsky,et al.  Insulin sensitivity: modulation by nutrients and inflammation. , 2008, The Journal of clinical investigation.

[34]  C. Ballantyne,et al.  Regulation of LFA-1-dependent inflammatory cell recruitment by Cbl-b and 14-3-3 proteins. , 2008, Blood.

[35]  K. Cianflone,et al.  Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo. , 2007, American journal of physiology. Endocrinology and metabolism.

[36]  A. Ferrante,et al.  Obesity‐induced inflammation: a metabolic dialogue in the language of inflammation , 2007, Journal of internal medicine.

[37]  K. Cianflone,et al.  Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout mice. , 2007, The Journal of endocrinology.

[38]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[39]  Hongwei Jiang,et al.  TIMP-1 Transgenic Mice Recover From Diabetes Induced by Multiple Low-Dose Streptozotocin , 2007, Diabetes.

[40]  A. Saltiel,et al.  Increased Inflammatory Properties of Adipose Tissue Macrophages Recruited During Diet-Induced Obesity , 2007, Diabetes.

[41]  Avner Bar Hen,et al.  Increased Infiltration of Macrophages in Omental Adipose Tissue Is Associated With Marked Hepatic Lesions in Morbid Human Obesity , 2006, Diabetes.

[42]  R. Kitazawa,et al.  MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. , 2006, The Journal of clinical investigation.

[43]  Shupei Wang,et al.  Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans Published, JLR Papers in Press, September 8, 2005. DOI 10.1194/jlr.M500294-JLR200 , 2005, Journal of Lipid Research.

[44]  J. Köhl,et al.  Opposing Regulatory Roles of Complement Factor 5 in the Development of Bleomycin-Induced Pulmonary Fibrosis1 , 2005, The Journal of Immunology.

[45]  Jörg Köhl,et al.  Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans , 2005, Nature Genetics.

[46]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[47]  Per Westermark,et al.  Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. , 2004, The Journal of clinical endocrinology and metabolism.

[48]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[49]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[50]  P. Monk,et al.  The Chemoattractant Receptor-like Protein C5L2 Binds the C3a des-Arg77/Acylation-stimulating Protein* , 2003, The Journal of Biological Chemistry.

[51]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[52]  Vu,et al.  Plasma acylation stimulating protein, adipsin and lipids in non‐obese and obese populations , 1999, European journal of clinical investigation.

[53]  U. Höpken,et al.  The C5a chemoattractant receptor mediates mucosal defence to infection , 1996, Nature.

[54]  B. Spiegelman,et al.  Adipsin and an endogenous pathway of complement from adipose cells. , 1992, The Journal of biological chemistry.

[55]  John D Lambris,et al.  C5L2 receptor disruption enhances the development of diet-induced insulin resistance in mice. , 2013, Immunobiology.

[56]  P. Nilsson,et al.  Platelets, complement, and contact activation: partners in inflammation and thrombosis. , 2012, Advances in experimental medicine and biology.

[57]  K. Cianflone,et al.  Adipokines and the immune system: an adipocentric view. , 2008, Advances in experimental medicine and biology.

[58]  A. Saltiel,et al.  Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. , 2007, American journal of physiology. Endocrinology and metabolism.

[59]  P. Mcgeer,et al.  Complement activation by islet amyloid polypeptide (IAPP) and alpha-synuclein 112. , 2007, Biochemical and biophysical research communications.